Fibrolamellar variant of hepatocellular carcinoma

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 101-110

  Chun, Yun Shin ^a   Zimmitti, Giuseppe ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; IODINATED POPPYSEED OIL I 131; RADIOPHARMACEUTICAL AGENT; RECOMBINANT ALPHA2B INTERFERON; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; CANCER MORPHOLOGY; CANCER PROGNOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EPIGENETICS; FIBROLAMELLAR VARIANT OF LIVER CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HEMANGIOMA; LIVER HILUS; LIVER HYPERPLASIA; LIVER RESECTION; LIVER SCINTISCANNING; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR CALCINOSIS; TUMOR DIFFERENTIATION;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84868314554     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_7     Document Type: Article

References (33)

1. Edmondson HA (1956) Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child 91:168-186
2. Craig JR, Peters RL, Edmondson HA, Omata M (1980) Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46:372-379 (Pubitemid 10085954)
3. Berman MM, Libbey NP, Foster JH (1980) Hepatocellular carcinoma. Polygonal cell type with fibrous stroma - an atypical variant with a favorable prognosis. Cancer 46:1448-1455 (Pubitemid 11253534)
4. Torbenson M (2007) Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol 14:217-223 (Pubitemid 46659192)
5. El-Serag HB, Davila JA (2004) Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39:798-803 (Pubitemid 38337660)
6. Okuda K (2002) Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 17:401-405 (Pubitemid 34534077)
7. Payne CM, Nagle RB, Paplanus SH, Graham AR (1986) Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid? Ultrastruct Pathol 10:539-552 (Pubitemid 17000940)
8. Ward SC, Huang J, Tickoo SK, Thung SN, Ladanyi M, Klimstra DS (2010) Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol 23:1180-1190
9. Agarwal VR, Takayama K, Van Wyk JJ, Sasano H, Simpson ER, Bulun SE (1998) Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab 83:1797-1800 (Pubitemid 28501061)
10. Muramori K, Taguchi S, Taguchi T, Kohashi K, Furuya K, Tokuda K, Ishii E (2011) High aromatase activity and overexpression of epidermal growth factor receptor in fibrolamellar hepatocellular carcinoma in a child. J Pediatr Hematol Oncol 33:e195-197
11. Pinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, Casavilla A, Dvorchik I, Fung JJ, Starzl TE (1997) Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26:877-883 (Pubitemid 27413652)
12. Kanai T, Takabayashi T, Kawano Y, Kuramochi S, Miyazawa N (2004) A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female. Jpn J Clin Oncol 34:346-351 (Pubitemid 43115317)
13. Waxman S, Gilbert HS (1973) A tumor-related vitamin B12 binding protein in adolescent hepatoma. N Engl J Med 289:1053-1056
14. Paradinas FJ, Melia WM, Wilkinson ML, Portmann B, Johnson PJ, Murray-Lyon IM, Williams R (1982) High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed) 285:840-842 (Pubitemid 12067725)
15. Lildballe DL, Nguyen KQ, Poulsen SS, Nielsen HO, Nexo E (2011) Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. Eur J Surg Oncol 37:72-79
16. Ward SC, Waxman S (2011) Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors. Semin Liver Dis 31:61-70
17. Ehrenfried JA, Zhou Z, Thompson JC, Evers BM (1994) Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma. Ann Surg 220:484-489; discussion 489-491
18. McLarney JK, Rucker PT, Bender GN, Goodman ZD, Kashitani N, RosPR (1999) Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics 19:453-471
19. Chung YE, Park MS, Park YN, Lee HJ, Seok JY, Yu JS, Kim MJ (2009) Hepatocellular carcinoma variants: radiologic-pathologic correlation. Am J Roentgenol 193:W7-13
20. Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W (1999) Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213:352-361 (Pubitemid 29510577)
21. El-Gazzaz G, Wong W, El-Hadary MK, Gunson BK, Mirza DF, Mayer AD, Buckels JA, McMaster P (2000) Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int 13(Suppl 1):S406-409
22. Maniaci V, Davidson BR, Rolles K, Dhillon AP, Hackshaw A, Begent RH, Meyer T (2009) Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol 35:617-621
23. Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D'Angelica M, Abou-Alfa G, Blumgart LH, DeMatteo RP (2006) Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 106:1331-1338 (Pubitemid 43363911)
24. Spence RA, Rosen A, Krige JE, Blumgart RL, Temple-Camp CR, Terblanche J (1987) Unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin. A case report. S Afr Med J 72:701-703 (Pubitemid 18086512)
25. Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM (2003) Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 21:421-427 (Pubitemid 46606469)
26. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97:2006-2012 (Pubitemid 36397279)
27. Hemming AW, Langer B, Sheiner P, Greig PD, Taylor BR (1997) Aggressive surgical management of fibrolamellar hepatocellular carcinoma. J Gastrointest Surg 1:342-346 (Pubitemid 127432780)
28. Dhingra S, Li W, Tan D, Zenali M, Zhang H, Brown RE (2010) Cell cycle biology of fibrolamellar hepatocellular carcinoma. Int J Clin Exp Pathol 3:792-797
29. Buckley AF, Burgart LJ, Kakar S (2006) Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. Hum Pathol 37:410-414
30. Orsatti G, Hytiroglou P, Thung SN, Ishak KG, Paronetto F (1997) Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver 17:152-156 (Pubitemid 27363867)
31. Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM (2003) HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Mod Pathol 16:14-21 (Pubitemid 36152681)
32. Zenali MJ, Tan D, Li W, Dhingra S, Brown RE (2010) Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma. Ann Clin Lab Sci 40:126-134
33. Tanaka K, Honna T, Kitano Y, Kuroda T, Morikawa N, Matsuda H, Kawashima N, Matsuoka K, Miyauchi J (2005) Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report. J Clin Pathol 58:884-887 (Pubitemid 41113401)